Back
Regions Financial Vs. Bright Minds Biosciences Industry Stock Comparison
Buy
67
RF
Regions Financial
Last Price:
27.22
Seasonality Move:
5.24%
Sell
25
DRUG
Bright Minds Biosciences
Last Price:
43.34
Seasonality Move:
-15.89%
Buy
67
Regions Financial (RF)
is a Buy
Is Regions Financial a Buy, Sell or Hold?
- The current Regions Financial [RF] share price is $27.26. The Score for RF is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- RF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
- The current Bright Minds Biosciences [DRUG] share price is $44.00. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RF Stock Price Chart
What is Regions Financial's stock price today?
-
The Regions Financial share price today is $27.26
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RF is experiencing slight buying pressure.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $44.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
RF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.89 | Buy |
| Relative Strength Index (14 RSI): | 72.27 | Buy |
| Chaikin Money Flow: | 322012 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.23 - 27.01) | Buy |
| Bollinger Bands (100): | (21.37 - 24.95) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.5 | Buy |
| Relative Strength Index (14 RSI): | 58.93 | Buy |
| Chaikin Money Flow: | 115403 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.12 - 49.42) | Buy |
| Bollinger Bands (100): | (-5.11 - 34.85) | Buy |
RF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.98 | Buy |
| 20-day SMA: | 26.06 | Buy |
| 50-day SMA: | 24.41 | Buy |
| 200-day SMA: | 21.26 | Buy |
| 8-day EMA: | 26.99 | Buy |
| 20-day EMA: | 26.17 | Buy |
| 50-day EMA: | 24.78 | Buy |
| 200-day EMA: | 21.9 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.17 | Buy |
| 20-day SMA: | 42.3 | Buy |
| 50-day SMA: | 28.61 | Buy |
| 200-day SMA: | 8.06 | Buy |
| 8-day EMA: | 39.27 | Buy |
| 20-day EMA: | 39.13 | Buy |
| 50-day EMA: | 31.07 | Buy |
| 200-day EMA: | 12.97 | Buy |
Regions Financial Earnings Growth & RF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and an increase next year of $0.16 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Regions Financial Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||